Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

UV rays can cause a type of hair loss known as telogen alopecia.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Minoxidil and finasteride can slow or halt hair loss, but may have side effects.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

New treatments for male hair loss show promise but need more research for safety and effectiveness.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

A child was initially wrongly diagnosed with a fungal scalp infection but actually had a non-scarring hair loss condition called Temporal Triangular Alopecia.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Hair transplantation effectively treated a woman's patchy hair loss when other treatments failed.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Hair restoration surgery has improved with better techniques for natural looks and managing patient expectations, but it remains labor-intensive and requires careful consideration of potential complications.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

The document suggests recognizing "trichiatrists" as doctors specializing in hair and scalp health, using evidence-based treatments.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Stopping imipramine reduced the woman's hair loss.

Hair loss, known as androgenic alopecia, can start in teenage years and may not always be hormone-related. It's important to do extra tests in young cases and remember it can greatly affect a teenager's mental health.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.